Biochemical Cardiac Markers in Clinical Cardiology

Authors

  • Palanisamy Pasupathi Head- Department of Clinical Biochemistry, Institute of Laboratory Medicine, K.G. Hospital and Post Graduate Medical Institute, Coimbatore-641 018, Tamil Nadu
  • Y Yagneswara Rao Chief-Cardiologist, Department of Cardiology, K.G. Hospital and Post Graduate Medical Institute, Coimbatore-641 018, Tamil Nadu
  • Jawahar Farook onsultant Cardiologist, Department of Cardiology, K.G. Hospital and Post Graduate Medical Institute, Coimbatore-641 018, Tamil Nadu
  • Govindaswamy Bakthavathsalam Professor, Department of Surgery, K.G. Hospital and Post Graduate Medical Institute, Coimbatore- 641 018, Tamil Nadu

DOI:

https://doi.org/10.3329/jom.v10i2.2824

Keywords:

Biochemical markers, Myocardial infarction, Troponin, Brain natriuretic peptide

Abstract

Millions of patients present annually with chest pain, but only 10% to 15% have myocardial infarction. Lack of diagnostic sensitivity and specificity of clinical and conventional markers prevents or delays treatment and leads to unnecessary costly admissions. Comparative data are lacking on the new markers, yet using all of them is inappropriate and expensive. The biochemical marker determination to clinical cardiology and discusses some important developments in this field. Biochemical markers play a pivotal role in the diagnosis and management of patients with acute coronary syndrome (ACS), as witnessed by the incorporation of cardiac troponins into new international guidelines for patients with ACS and in the redefinition of myocardial infarction. Despite the success of cardiac troponins, there is still a need for the development of early markers that can reliably rule out ACS from the emergency room at presentation and also detect myocardial ischaemia in the absence of irreversible myocyte injury. The cardiac natriuretic peptides, Laboratory Medicine are also assuming a role in the assessment of cardiac function. Biochemical markers now play an important role in the detection of disease, risk stratification and the monitoring of therapy.

Keywords: Biochemical markers, Myocardial infarction, Troponin, Brain natriuretic peptide  

doi: 10.3329/jom.v10i2.2824  

J MEDICINE 2009; 10 : 100-108

Downloads

Download data is not yet available.
Abstract
147
PDF
1454

Downloads

How to Cite

Pasupathi, P., Rao, Y. Y., Farook, J., & Bakthavathsalam, G. (2009). Biochemical Cardiac Markers in Clinical Cardiology. Journal of Medicine, 10(2), 100–108. https://doi.org/10.3329/jom.v10i2.2824

Issue

Vol. 10 No. 2 (2009)

Section

Review Articles

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

  1. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).